Purchase Order 75N92B20P00007

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,084.00 on December 12, 2017. The order covers custom single-cell RNA-sequencing services using 10X Genomics technology. Place of performance is Pleasanton, California. The period of performance runs from December 12, 2017 through December 11, 2018, with an ultimate completion date of January 31, 2018. The contract is firm fixed price with no set-aside category...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $23,534.00 on August 7, 2018. Performance is located in Pleasanton, California. The order period runs from August 7, 2018 through August 6, 2019. 10X Genomics supplies single-cell and spatial transcriptomics platforms, reagents, and consumables to federal research agencies.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $20,509.00 on July 9, 2018, with completion on July 8, 2019. Performance took place in Pleasanton, California. The order was issued on a firm fixed price basis with no small business set-aside. The source does not specify the items or services procured.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,124.00 on September 20, 2019, with completion on September 27, 2019. The order is a firm fixed price, commercial item acquisition with no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures genomic analysis instruments, consumables, or related bioinformatics products from 10X Genomics' single-cell and spatial transcriptomics...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $24,084.00 on January 19, 2018. The order procures custom chromium single cell analysis reagents and consumables (3'/5' - 10X Genomics configuration). Performance occurs at 10X Genomics' facility in Pleasanton, California. The period of performance runs from January 19, 2018 through January 18, 2019, with ultimate completion targeted for February 28, 2018. The...

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $22,285.50 on September 10, 2019, with completion by September 9, 2020. No set-aside applied. Work is performed at Bethesda, Maryland. The order is priced on a firm fixed price basis for genomic analysis instruments, consumables, or reagents consistent with the vendor's product portfolio of single-cell and spatial transcriptomics platforms and associated kits.

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a purchase order to 10X Genomics, Inc. valued at $21,581 with an award date of December 12, 2017. Work is performed in Bethesda, Maryland. The order covers genomic analysis instruments and consumables under a firm fixed price arrangement with a period of performance from December 12, 2017 through December 11, 2018.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on June 19, 2018, with ultimate completion on July 19, 2018. No set-aside was used. Work is performed in Pleasanton, California. The order procures genomic analysis instruments, consumables, or reagents consistent with the vendor's core capability in single-cell and spatial transcriptomics platforms and associated products supplied to federal research...

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. for $22,310.60 on February 19, 2019, with completion on February 18, 2020. No set-aside was used. Performance occurs in Pleasanton, California. The order is priced on a firm fixed price basis for commercial genomic analysis instruments, consumables, or bioinformatics software supporting the institute's research operations.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to 10X Genomics, Inc. on August 20, 2018, with a ceiling value of $23,245.00 and a firm fixed price. No set-aside was used. Performance is located in Pleasanton, California. The order was ultimately completed on August 19, 2019.</p>